Stock A314130 GENOME & COMPANY
Add to a list
To use this feature you must be a member
Log inSign up

Funds and ETFs Genome & Company

Equities

A314130

KR7314130006

Biotechnology & Medical Research

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
6,710 KRW +2.29% Intraday chart for Genome & Company -4.55% -46.28%
Jan. 24 Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio®? for the Treatment of Gastric Cancer Poster Presented at ASCO GI CI
2023 Genome & Company Announces Positive Results from Interim Analysis of Gen-001 Plus Avelumab (Bavencio®?) Phase II Trial CI

Company Profile

Genome&Company is a company mainly engaged in the research, development, manufacturing and sale of probiotics. Probiotics are mainly used in products including immune oncology therapeutic supplements, dietary supplements, cosmetics and medicines. These products are mainly applied to obesity, diabetes, acne, atopic dermatitis, and cancer complementary therapies.
Sector
Biotechnology & Medical Research
Calendar
2024-05-12 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
GENOME & COMPANY Stock Genome & Company
-46.28% 73.04M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.77% 42.86B
MODERNA, INC. Stock Moderna, Inc.
+12.24% 42.74B
LONZA GROUP AG Stock Lonza Group AG
+44.02% 41.36B
CELLTRION, INC. Stock Celltrion, Inc.
-8.83% 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+7.44% 25.15B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-23.01% 18.63B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+30.56% 12.37B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.82% 11.92B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+8.35% 11.21B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. A314130 Stock
  4. Funds and ETFs Genome & Company